Milan, Italy — Hunan Huateng Pharmaceutical Co., Ltd. will participate in CPHI Milan 2026, October 6–8 at Fiera Milano, where the company will present its PEG products and pharmaceutical CDMO capabilities to customers and partners from the global pharmaceutical industry.

At Booth 3H94, Huateng Pharma will showcase a range of PEG derivatives, including linear PEGs, lipid PEGs, multi-arm PEGs, monodispersed PEGs, and polydispersed PEGs. The products are used as building blocks and reagents in areas including bioconjugation, drug delivery, and pharmaceutical research.

The company will also present its CDMO capabilities for pharmaceutical intermediates and specialty chemicals, covering project stages from route design and process development to process optimization, validation, and production.

“We hope to provide our customers with high-purity products and reliable manufacturing support for their pharmaceutical and biopharmaceutical projects,” said Jack Deng, CEO of Hunan Huateng Pharmaceutical Co., Ltd. “CPHI Milan gives us an opportunity to meet customers and partners in person, understand their project requirements, and discuss how we can support their development and manufacturing needs.”

In addition to PEG derivatives, Huateng Pharma will display selected pharmaceutical intermediates, veterinary APIs, cosmetic ingredients, and fine chemicals at the exhibition. The company supports projects ranging from research-scale requirements to larger-scale production, with both non-GMP and GMP manufacturing capabilities.

Visitors to CPHI Milan are welcome to meet the Huateng Pharma team at Booth 3H94 to discuss PEG products, pharmaceutical intermediates, CDMO projects, and potential cooperation.

Event Details

Event: CPHI Milan 2026
Date: October 6–8, 2026
Venue: Fiera Milano, Milan, Italy
Booth: 3H94

About Hunan Huateng Pharmaceutical Co., Ltd.

Hunan Huateng Pharmaceutical Co., Ltd. specializes in the development and manufacturing of PEG derivatives, pharmaceutical intermediates, APIs, and specialty chemicals. The company provides PEG products and CDMO services to support pharmaceutical and biopharmaceutical development, from research and process development to manufacturing.

Media & Business Contact
Hunan Huateng Pharmaceutical Co., Ltd.
sales@huatengusa.com